MedTrace Logo

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

NCT00936260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2009-07-10

No results posted yet for this study

Summary

The purpose of this study is to determine the duration of the treatment with alendronate in postmenopausal women with osteoporosis.

Conditions

Interventions

DRUG

alendronate

several duration of treatment

Sponsors & Collaborators

  • Ciudad Universitaria, Spain

    lead OTHER

Principal Investigators

  • Carlos Lozano Tonkin, doctor · university san carlos hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-31
Primary Completion
2004-12-31
Completion
2004-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936260 on ClinicalTrials.gov